Functional and organic components of diastolic dysfunction in hypertensive heart disease: therapeutic implications

D Sagastagoitia1, M Morillas, N Murga

  • 1Vizcaya Pro-Cardiacos Institute of Cardiology, Hospital Civil de Basurto, Bilbao, Bizkaia, Spain.

European Heart Journal
|November 1, 1993
PubMed

Insights

Hypertension impairs left ventricular diastolic function through structural and functional changes. Drug therapy initially improves function by targeting functional determinants, with long-term benefits from structural modifications.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diastolic Dysfunction

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Left ventricular diastolic dysfunction is a common complication of hypertension.
  • Understanding the determinants of diastolic dysfunction is crucial for effective management.

Purpose of the Study:

  • To review the structural and functional determinants of impaired left ventricular diastolic function in hypertensive patients.
  • To discuss the indices used for detecting diastolic dysfunction.
  • To elucidate the impact of therapeutic interventions on these determinants.

Main Methods:

  • Literature review of studies on hypertensive heart disease.
  • Analysis of physiological and structural changes affecting diastolic function.
  • Examination of the effects of pharmacological interventions.

Main Results:

  • Impaired diastolic function in hypertension involves both structural and functional determinants.
  • Functional determinants are amenable to rapid modification.
  • Structural determinants require long-term interventions for modification.

Conclusions:

  • Drug therapy for hypertension initially targets functional determinants of diastolic dysfunction.
  • Sustained therapeutic efforts lead to the modification of structural factors.
  • This dual action of therapy results in long-term improvement of left ventricular diastolic function.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

No description available
4.3K
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539